Software for building transition metal complexes in 3D
Snowdrop Science Ltd develops software for building organometallic complexes atom by atom and preparing their 3D structures for quantum chemical calculations. The work so far has focused on half-sandwich ruthenium(II) arene complexes, a class of compounds studied as anticancer agents [1, 2].
Software
Building
Atoms and bonds are placed by hand in a 3D view. Each structure records the hapticity of every ligand bound to a metal through several atoms, such as the η6 arene in RM175, together with chelating ligands, dative metal–ligand bonds and formal charges.
Clean up
The Clean up command positions atoms using structural chemistry rules. These set valence shell electron pair repulsion (VSEPR) geometries, close aromatic rings, place chelating ligands and seat a ligand bound through several atoms, such as an η6 arene, on one face of an octahedral metal centre. The result is a starting geometry for the Minimise command.
Minimise
The Minimise command optimises the structure with the semi-empirical method GFN2-xTB in implicit water, using the ALPB solvation model [4, 5]. Weak harmonic restraints are applied to the metal coordination sphere during the optimisation. A result is accepted only if the optimisation converges to a gradient norm below 0.001 hartree per bohr and no bond is broken or formed. For the ruthenium arene complexes, all six ruthenium–carbon distances to the arene must also stay between 1.80 and 2.60 Å and within 0.25 Å of each other.
Export
Each exported structure records, for every atom, whether its coordinates came from Clean up or from Minimise. Before a file is saved under an existing compound name, the software checks that the molecule’s bond graph matches the graph recorded for that name.
Validation
Thirteen ruthenium(II) arene complexes with published crystal structures [1, 6] were optimised with GFN2-xTB in implicit water, without restraints, starting from their crystal coordinates. Table 1 compares each optimised structure with its crystal structure.
| Complex | CCDC | Arene | Chelating ligand | RMSD | Ru to arene centroid | Ru–N | Ru–Cl |
|---|---|---|---|---|---|---|---|
| RM175 | 170362 | biphenyl | ethylenediamine | 0.161 | 0.131 | 0.007 | 0.022 |
| 16 | 607563 | fluorene | ethylenediamine | 0.117 | 0.122 | 0.006 | 0.028 |
| 22 | 607565 | tetralin | ethylenediamine | 0.123 | 0.116 | 0.003 | 0.024 |
| 27 | 607573 | indan | 1,3-diamino-2-propanol | 0.100 | 0.140 | 0.016 | 0.014 |
| 28 | 607562 | indan | homopiperazine | 0.080 | 0.147 | 0.024 | 0.032 |
| 36 | 607564 | tetrahydroanthracene | 1,2-diaminobenzene | 0.506 | 0.129 | 0.021 | 0.004 |
| 38 | 607570 | indan | 2,2′-bipyridine | 0.083 | 0.189 | 0.106 | 0.029 |
| 39 | 607572 | biphenyl | 2,2′-bipyridine | 0.122 | 0.157 | 0.095 | 0.014 |
| 43 | 607571 | indan | 1,10-phenanthroline | 0.072 | 0.177 | 0.089 | 0.035 |
| 53 | 607567 | p-cymene | 8-hydroxyquinolinate | 0.176 | 0.158 | 0.085 | 0.022 |
| 60 | 607574 | p-cymene | 2,2,6,6- | 0.354 | 0.179 | n/a | 0.021 |
| 61 | 607566 | p-cymene | hexafluoroacetylacetonate | 0.464 | 0.203 | n/a | 0.043 |
| 62 | 607568 | p-cymene | chromenone diketonate | 0.580 | 0.187 | n/a | 0.019 |
All 13 optimisations converged with no bonds broken or formed. The median differences were 0.022 Å for Ru–N bonds in the 10 complexes with nitrogen donors, 0.022 Å for Ru–Cl bonds and 0.68° for the chelate bite angle. The median heavy-atom RMSD was 0.12 Å.
Two differences are systematic. GFN2-xTB placed ruthenium on average 0.16 Å further from the arene centroid than in the crystal structures, and it shortened bonds to aromatic nitrogen donors by 0.085 to 0.106 Å. In the four complexes with the largest RMSD, 0.35 to 0.58 Å, the Ru–Cl differences are still at most 0.043 Å. Their RMSD comes from the orientation of fused rings and ligand substituents. The crystal structures are solids that include counter-ions, while the calculations model a single complex in implicit water.
RM175 compared with density functional theory
RM175 was also optimised with density functional theory, using the ωB97M-V functional [8], the def2-SVP basis set [9] with an effective core potential for ruthenium [10] and the SMD water model [11]. The calculation ran on a cloud GPU with PySCF and GPU4PySCF [12, 13]. A vibrational frequency calculation supports a local minimum. Table 2 follows RM175 through each stage.
| Structure | Ru–Cl | Ru–N | Mean Ru–C | Ru height above arene | N–Ru–N | RMSD to crystal |
|---|---|---|---|---|---|---|
| Crystal structure, CCDC 170362 | 2.408 | 2.111, 2.120 | 2.178 | 1.661 | 79.2 | 0.00 |
| Clean up | 2.480 | 2.170, 2.170 | 2.220 | 1.723 | 90.0 | 1.53 |
| Clean up, then GFN2-xTB | 2.389 | 2.120, 2.131 | 2.278 | 1.786 | 79.2 | 1.46 |
| DFT, ωB97M-V/def2-SVP | 2.406 | 2.116, 2.122 | 2.192 | 1.669 | 79.7 | 1.05 |
The DFT structure matches the crystal structure to within 0.014 Å for the Ru–Cl, Ru–N and mean Ru–C distances. Its arene is rotated by 69° about the axis from ruthenium to the arene centroid relative to the crystal structure, which accounts for most of its 1.05 Å RMSD. Clean up alone sets an ideal 90° N–Ru–N angle, and GFN2-xTB relaxes it to 79.2°, the crystal value. The GFN2-xTB structure keeps a different ligand orientation from the crystal structure, so its RMSD stays at 1.46 Å.
Company
Snowdrop Science Ltd is a private limited company registered in England and Wales, company number 16848046, incorporated in November 2025.
Jed Walsh founded the company and is its director. In his MChem research at the University of Leeds, he developed an inline method for determining the encapsulation efficiency of RNA lipid nanoparticles. In 2024 he took second place in the Reckitt Sustainability Challenge. The name Snowdrop Science is a dedication to his grandmother. The chemotherapy drug she received had poor selectivity for cancer cells, and that experience led him to work on metal-based anticancer compounds beyond platinum that could act more selectively.
Contact
For questions about the software or the validation results, email jed.walsh@snowdropscience.co.uk.
References
- 1R. E. Morris et al., J. Med. Chem. 2001, 44, 3616. doi.org/10.1021/jm010051m
- 2R. E. Aird et al., Br. J. Cancer 2002, 86, 1652. doi.org/10.1038/sj.bjc.6600290
- 3CCDC 170362, Experimental Crystal Structure Determination, Cambridge Crystallographic Data Centre, 2001. doi.org/10.5517/cc5q8kp
- 4C. Bannwarth, S. Ehlert and S. Grimme, J. Chem. Theory Comput. 2019, 15, 1652. doi.org/10.1021/acs.jctc.8b01176
- 5S. Ehlert, M. Stahn, S. Spicher and S. Grimme, J. Chem. Theory Comput. 2021, 17, 4250. doi.org/10.1021/acs.jctc.1c00471
- 6A. Habtemariam et al., J. Med. Chem. 2006, 49, 6858. doi.org/10.1021/jm060596m
- 7W. Kabsch, Acta Crystallogr. A 1976, 32, 922. doi.org/10.1107/S0567739476001873
- 8N. Mardirossian and M. Head-Gordon, J. Chem. Phys. 2016, 144, 214110. doi.org/10.1063/1.4952647
- 9F. Weigend and R. Ahlrichs, Phys. Chem. Chem. Phys. 2005, 7, 3297. doi.org/10.1039/B508541A
- 10D. Andrae, U. Häußermann, M. Dolg, H. Stoll and H. Preuß, Theor. Chim. Acta 1990, 77, 123. doi.org/10.1007/BF01114537
- 11A. V. Marenich, C. J. Cramer and D. G. Truhlar, J. Phys. Chem. B 2009, 113, 6378. doi.org/10.1021/jp810292n
- 12Q. Sun et al., J. Chem. Phys. 2020, 153, 024109. doi.org/10.1063/5.0006074
- 13X. Wu et al., WIREs Comput. Mol. Sci. 2025, 15, e70008. doi.org/10.1002/wcms.70008